V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Akoya Biosciences (AKYA) FINANCIAL RESULTS FOR THE FOURTH QUARTER 2021.

Start-ups and IPO

15.03.2022

Non-GAAP net loss per share for the fourth quarter of 2021 was $-0.47.

Revenue was $16.20million, up 25.5% from the same period last year.

Categories